Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -712M | -83.26%-821M | -21.69%-763M | 38.59%-1.78B | -2.75%-448M | 23.16%-627M | 35.62%-2.91B | -49.23%-1.06B | 54.57%-592M | 62.09%-436M |
| Net profit before non-cash adjustment | --569M | -364.99%-2.13B | -2.71%-2.58B | -12.00%-4.06B | 22.01%-457M | -241.63%-2.51B | 31.97%-3.63B | -50.42%-1.6B | 32.86%-709M | 67.41%-586M |
| Total adjustment of non-cash items | ---1.25B | 386.41%1.4B | 19.67%1.89B | 150.15%1.68B | 617.50%287M | 6,773.91%1.58B | -8.57%672M | 282.31%497M | -43.15%112M | -87.54%40M |
| -Depreciation and amortization | --68M | -6.94%67M | -6.85%68M | 32.59%297M | -8.86%72M | -48.23%73M | -41.97%224M | -170.87%-73M | -23.76%77M | -14.13%79M |
| -Share of associates | --0 | 0.00%1M | --0 | 200.00%2M | --1M | --0 | 33.33%-2M | --0 | ---2M | --0 |
| -Disposal profit | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Other non-cash items | ---1.32B | 520.56%1.33B | 20.95%1.82B | 207.11%1.38B | 648.72%214M | 1,377.97%1.51B | 27.84%450M | 2,092.31%570M | -61.46%37M | -117.11%-39M |
| Changes in working capital | ---29M | 66.91%-92M | -125.08%-76M | 1,116.33%596M | -352.73%-278M | 391.35%303M | -40.96%49M | -82.73%38M | 101.13%5M | -66.36%110M |
| -Change in receivables | ---19M | 85.78%-33M | 571.43%66M | 850.00%150M | -192.80%-232M | 62.16%-14M | -115.38%-20M | -108.57%-219M | -109.86%-14M | 47.06%250M |
| -Change in payables | --2M | 67.79%-48M | -175.36%-52M | 201.79%57M | -52.04%-149M | 230.19%69M | 57.89%-56M | -66.12%41M | 109.22%54M | -151.31%-98M |
| -Changes in other current assets | ---25M | -216.67%-14M | -107.11%-16M | 0.00%210M | -50.00%12M | 650.00%225M | 337.50%210M | 37.89%222M | -371.43%-66M | 160.00%24M |
| -Changes in other current liabilities | --13M | -96.70%3M | -421.74%-74M | 310.59%179M | 237.88%91M | 152.27%23M | -323.68%-85M | -113.95%-6M | 121.43%31M | -1,200.00%-66M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | -7M | 46.34%-22M | -250.00%-7M | 10.96%-65M | 18.00%-41M | 77.78%-2M | 12.05%-73M | -150.00%-25M | 210.00%11M | 1.96%-50M |
| Interest received (cash flow from operating activities) | -23M | 211.11%28M | -33.33%10M | 150.00%35M | 9M | 275.00%15M | 1,300.00%14M | 600.00%7M | 3M | 0 |
| Tax refund paid | -8M | 0 | 0.00%-2M | 50.00%-4M | 0.00%-2M | 66.67%-2M | -14.29%-8M | 0 | 0 | -2M |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | -99.33%1M | -200.00%-1M | -99.33%1M | 150M | 1M | -1M | 150.00%1M |
| Operating cash flow | ---750M | -68.74%-815M | -23.90%-762M | 35.61%-1.82B | 0.82%-483M | 9.29%-615M | 38.67%-2.82B | -49.72%-1.08B | 55.90%-579M | 59.52%-487M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | ---58M | -25.00%-5M | -140.00%-12M | 40.00%-15M | 80.95%-4M | -400.00%-5M | 87.92%-25M | 84.21%-3M | --0 | 66.13%-21M |
| Net intangibles purchase and sale | ---- | ---- | ---- | -9,633.33%-292M | -29,100.00%-292M | --0 | 94.55%-3M | ---1M | --0 | 0.00%-1M |
| Net investment product transactions | --1M | -62.40%-406M | -938.46%-270M | 3.48%-1.11B | -1,186.96%-250M | 95.09%-26M | -90.08%-1.15B | -12.66%-89M | -2,538.10%-554M | 105.84%23M |
| Advance cash and loans provided to other parties | ---- | ---- | --0 | ---- | ---- | ---337M | ---- | ---- | ---- | ---- |
| Net changes in other investments | ---3M | ---- | ---- | -101.75%-1M | ---- | ---- | 235.71%57M | --0 | --0 | 900.00%8M |
| Investing cash flow | ---60M | -99.05%-418M | 23.37%-282M | -26.49%-1.42B | -2,433.33%-210M | 23.81%-368M | -23.32%-1.12B | 7.00%-93M | -638.67%-554M | 101.97%9M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | --0 | ---- | ---- | 5.84%-2.4B | ---- | ---- | 49.00%-2.55B | ---2.55B | --0 | ---- |
| Net common stock issuance | --1.08B | 2,268.75%1.39B | 10.51%2.48B | -30.98%2.15B | -6,500.00%-64M | 1,904.46%2.25B | 40.51%3.12B | --0 | 167.56%3B | 150.00%1M |
| Increase or decrease of lease financing | ---33M | 14.71%-29M | 14.71%-29M | 8.15%-124M | -3.03%-34M | 2.86%-34M | 27.03%-135M | 8.33%-33M | 20.93%-34M | 38.89%-33M |
| Issuance fees | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other fund-raising expenses | --3M | --674M | --434M | -84.45%452M | ---- | ---- | 523.82%2.91B | 1,286.76%943M | 2,331.25%778M | -36.16%203M |
| Financing cash flow | --1.05B | 39.06%2.03B | 30.53%2.89B | -97.69%77M | 754.97%1.46B | 108.58%2.21B | 233.37%3.34B | -245.26%-1.64B | 196.32%3.75B | -34.73%171M |
| Net cash flow | ||||||||||
| Beginning cash position | --6.25B | -32.12%5.46B | -45.37%3.67B | -7.24%6.72B | 12.59%8.05B | -7.24%6.72B | -52.09%7.25B | 37.99%9.59B | -43.08%6.93B | -47.05%7.15B |
| Current changes in cash | --238M | 4.03%800M | 50.00%1.84B | -421.12%-3.16B | 350.49%769M | 1,315.84%1.23B | 92.44%-606M | -1,009.71%-2.81B | 149.52%2.61B | 78.06%-307M |
| Effect of exchange rate changes | --10M | -123.08%-18M | -152.58%-51M | 31.71%108M | -7.14%78M | 3,133.33%97M | -38.35%82M | -477.78%-52M | -14.55%47M | 23.53%84M |
| Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | 200.00%1M | ---1M | ---- | ---- | ---- |
| End cash Position | --6.5B | -29.78%6.25B | -32.12%5.46B | -45.37%3.67B | 28.41%8.89B | 12.59%8.05B | -7.24%6.72B | -7.24%6.72B | 37.99%9.59B | -43.08%6.93B |
| Free cash flow | ---808M | -5.26%-820M | -24.84%-774M | 25.47%-2.12B | -53.05%-779M | 8.82%-620M | 41.39%-2.85B | -46.41%-1.08B | 57.61%-579M | 59.79%-509M |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |